CLEVELAND, May 1, 2013 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), a leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced its participation at industry events during the month of May.
CBI PRO (10 th Forum on Patient Reported Outcomes) Philadelphia, PA May 6-7, 2013
Bill Gluck, D ATATRAK's VP of Clinical and Consulting Services, leads the discussion on Optimizing Comparative Effectiveness Research through a Rapid Learning Healthcare System on Tuesday, May 7, 2013 at 11:15AM.D ATATRAK is sponsoring, exhibiting and presenting at the 10 th Forum on Patient Reported Outcomes. To learn more about Technological and Strategic Advances in Data Collection and Analytics at this CBI hosted event, see www.cbinet.com. 5 th DIA China 2013 Annual Meeting Beijing, China May 12-15, 2013 D ATATRAK will be attending in support of its strategic partner, NTT DATA, who will be exhibiting the D ATATRAK ONE™ cloud-based, unified clinical research platform. The DIA China Meeting will bring together 1200 professional participants to focus on Patient Safety: A Sustained Focus from Scientific Ideas to Innovative Medicines. See www.diahome.org for more information. 2013 ASCO Annual Meeting Chicago, IL May 31-June 4, 2013 D ATATRAK will be exhibiting its D ATATRAK ONE™ Clinical Research Platform's Oncology Solution at the ASCO Annual '13 Meeting. This year's Annual Meeting will consist of 25,000 oncology professionals working together to Build Bridges to Conquer Cancer. For more information on the event, see chicago2013.asco.org. Join D ATATRAK Thought Leaders: http://ow.ly/kAvUU About D ATATRAK D ATATRAK International is a worldwide technology and services company delivering unified eClinical® solutions and related services for the clinical trials industry. D ATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via D ATATRAK's Clinical and Consulting Services™ group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The D ATATRAK ONE™ software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I – Phase IV drug and device studies in multiple languages throughout the world. D ATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit http://www.datatrak.net. Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on March 15, 2013 announcing its results for the fourth quarter and full year of 2012. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise. SOURCE DATATRAK International, Inc.